Cargando…

Novel Functional Peptide for Next-Generation Vital Pulp Therapy

Although vital pulp therapy should be performed by promoting the wound-healing capacity of dental pulp, existing pulp-capping materials were not developed with a focus on the pulpal repair process. In previous investigations of wound healing in dental pulp, we found that organic dentin matrix compon...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, M., Okamoto, M., Komichi, S., Huang, H., Matsumoto, S., Moriyama, K., Ohshima, J., Abe, S., Morita, M., Ali, M., Takebe, K., Kozaki, I., Fujimoto, A., Kanie, K., Kato, R., Uto, K., Ebara, M., Yamawaki-Ogata, A., Narita, Y., Takahashi, Y., Hayashi, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989233/
https://www.ncbi.nlm.nih.gov/pubmed/36415061
http://dx.doi.org/10.1177/00220345221135766
_version_ 1784901724983525376
author Watanabe, M.
Okamoto, M.
Komichi, S.
Huang, H.
Matsumoto, S.
Moriyama, K.
Ohshima, J.
Abe, S.
Morita, M.
Ali, M.
Takebe, K.
Kozaki, I.
Fujimoto, A.
Kanie, K.
Kato, R.
Uto, K.
Ebara, M.
Yamawaki-Ogata, A.
Narita, Y.
Takahashi, Y.
Hayashi, M.
author_facet Watanabe, M.
Okamoto, M.
Komichi, S.
Huang, H.
Matsumoto, S.
Moriyama, K.
Ohshima, J.
Abe, S.
Morita, M.
Ali, M.
Takebe, K.
Kozaki, I.
Fujimoto, A.
Kanie, K.
Kato, R.
Uto, K.
Ebara, M.
Yamawaki-Ogata, A.
Narita, Y.
Takahashi, Y.
Hayashi, M.
author_sort Watanabe, M.
collection PubMed
description Although vital pulp therapy should be performed by promoting the wound-healing capacity of dental pulp, existing pulp-capping materials were not developed with a focus on the pulpal repair process. In previous investigations of wound healing in dental pulp, we found that organic dentin matrix components (DMCs) were degraded by matrix metalloproteinase-20, and DMC degradation products containing protein S100A7 (S100A7) and protein S100A8 (S100A8) promoted the pulpal wound-healing process. However, the direct use of recombinant proteins as pulp-capping materials may cause clinical problems or lead to high medical costs. Thus, we hypothesized that functional peptides derived from recombinant proteins could solve the problems associated with direct use of such proteins. In this study, we identified functional peptides derived from the protein S100 family and investigated their effects on dental pulp tissue. We first performed amino acid sequence alignments of protein S100 family members from several mammalian sources, then identified candidate peptides. Next, we used a peptide array method that involved human dental pulp stem cells (hDPSCs) to evaluate the mineralization-inducing ability of each peptide. Our results supported the selection of 4 candidate functional peptides derived from proteins S100A8 and S100A9. Direct pulp-capping experiments in a rat model demonstrated that 1 S100A8-derived peptide induced greater tertiary dentin formation compared with the other peptides. To investigate the mechanism underlying this induction effect, we performed liquid chromatography–tandem mass spectrometry analysis using hDPSCs and the S100A8-derived peptide; the results suggested that this peptide promotes tertiary dentin formation by inhibiting inflammatory responses. In addition, this peptide was located in a hairpin region on the surface of S100A8 and could function by direct interaction with other molecules. In summary, this study demonstrated that a S100A8-derived functional peptide promoted wound healing in dental pulp; our findings provide insights for the development of next-generation biological vital pulp therapies.
format Online
Article
Text
id pubmed-9989233
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-99892332023-03-08 Novel Functional Peptide for Next-Generation Vital Pulp Therapy Watanabe, M. Okamoto, M. Komichi, S. Huang, H. Matsumoto, S. Moriyama, K. Ohshima, J. Abe, S. Morita, M. Ali, M. Takebe, K. Kozaki, I. Fujimoto, A. Kanie, K. Kato, R. Uto, K. Ebara, M. Yamawaki-Ogata, A. Narita, Y. Takahashi, Y. Hayashi, M. J Dent Res Research Reports Although vital pulp therapy should be performed by promoting the wound-healing capacity of dental pulp, existing pulp-capping materials were not developed with a focus on the pulpal repair process. In previous investigations of wound healing in dental pulp, we found that organic dentin matrix components (DMCs) were degraded by matrix metalloproteinase-20, and DMC degradation products containing protein S100A7 (S100A7) and protein S100A8 (S100A8) promoted the pulpal wound-healing process. However, the direct use of recombinant proteins as pulp-capping materials may cause clinical problems or lead to high medical costs. Thus, we hypothesized that functional peptides derived from recombinant proteins could solve the problems associated with direct use of such proteins. In this study, we identified functional peptides derived from the protein S100 family and investigated their effects on dental pulp tissue. We first performed amino acid sequence alignments of protein S100 family members from several mammalian sources, then identified candidate peptides. Next, we used a peptide array method that involved human dental pulp stem cells (hDPSCs) to evaluate the mineralization-inducing ability of each peptide. Our results supported the selection of 4 candidate functional peptides derived from proteins S100A8 and S100A9. Direct pulp-capping experiments in a rat model demonstrated that 1 S100A8-derived peptide induced greater tertiary dentin formation compared with the other peptides. To investigate the mechanism underlying this induction effect, we performed liquid chromatography–tandem mass spectrometry analysis using hDPSCs and the S100A8-derived peptide; the results suggested that this peptide promotes tertiary dentin formation by inhibiting inflammatory responses. In addition, this peptide was located in a hairpin region on the surface of S100A8 and could function by direct interaction with other molecules. In summary, this study demonstrated that a S100A8-derived functional peptide promoted wound healing in dental pulp; our findings provide insights for the development of next-generation biological vital pulp therapies. SAGE Publications 2022-11-22 2023-03 /pmc/articles/PMC9989233/ /pubmed/36415061 http://dx.doi.org/10.1177/00220345221135766 Text en © International Association for Dental Research and American Association for Dental, Oral, and Craniofacial Research 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Research Reports
Watanabe, M.
Okamoto, M.
Komichi, S.
Huang, H.
Matsumoto, S.
Moriyama, K.
Ohshima, J.
Abe, S.
Morita, M.
Ali, M.
Takebe, K.
Kozaki, I.
Fujimoto, A.
Kanie, K.
Kato, R.
Uto, K.
Ebara, M.
Yamawaki-Ogata, A.
Narita, Y.
Takahashi, Y.
Hayashi, M.
Novel Functional Peptide for Next-Generation Vital Pulp Therapy
title Novel Functional Peptide for Next-Generation Vital Pulp Therapy
title_full Novel Functional Peptide for Next-Generation Vital Pulp Therapy
title_fullStr Novel Functional Peptide for Next-Generation Vital Pulp Therapy
title_full_unstemmed Novel Functional Peptide for Next-Generation Vital Pulp Therapy
title_short Novel Functional Peptide for Next-Generation Vital Pulp Therapy
title_sort novel functional peptide for next-generation vital pulp therapy
topic Research Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989233/
https://www.ncbi.nlm.nih.gov/pubmed/36415061
http://dx.doi.org/10.1177/00220345221135766
work_keys_str_mv AT watanabem novelfunctionalpeptidefornextgenerationvitalpulptherapy
AT okamotom novelfunctionalpeptidefornextgenerationvitalpulptherapy
AT komichis novelfunctionalpeptidefornextgenerationvitalpulptherapy
AT huangh novelfunctionalpeptidefornextgenerationvitalpulptherapy
AT matsumotos novelfunctionalpeptidefornextgenerationvitalpulptherapy
AT moriyamak novelfunctionalpeptidefornextgenerationvitalpulptherapy
AT ohshimaj novelfunctionalpeptidefornextgenerationvitalpulptherapy
AT abes novelfunctionalpeptidefornextgenerationvitalpulptherapy
AT moritam novelfunctionalpeptidefornextgenerationvitalpulptherapy
AT alim novelfunctionalpeptidefornextgenerationvitalpulptherapy
AT takebek novelfunctionalpeptidefornextgenerationvitalpulptherapy
AT kozakii novelfunctionalpeptidefornextgenerationvitalpulptherapy
AT fujimotoa novelfunctionalpeptidefornextgenerationvitalpulptherapy
AT kaniek novelfunctionalpeptidefornextgenerationvitalpulptherapy
AT kator novelfunctionalpeptidefornextgenerationvitalpulptherapy
AT utok novelfunctionalpeptidefornextgenerationvitalpulptherapy
AT ebaram novelfunctionalpeptidefornextgenerationvitalpulptherapy
AT yamawakiogataa novelfunctionalpeptidefornextgenerationvitalpulptherapy
AT naritay novelfunctionalpeptidefornextgenerationvitalpulptherapy
AT takahashiy novelfunctionalpeptidefornextgenerationvitalpulptherapy
AT hayashim novelfunctionalpeptidefornextgenerationvitalpulptherapy